Note: Ingredients listed on restricted chemical lists
EC/CAS
5124-30-1
Name of the chemical
4,4'-methylenedicyclohexyl diisocyanate
Concentration
N/A
General Information
Revision date
2019-08-01
Product name
ISOCYANATES, TOXIC, N.O.S. or ISOCYANATE SOLUTION, TOXIC, N.O.S
Product Synonyms
4, 4"-Dicyclohexylmethane diisocyanate
CAS No.
5124-30-1
1.2.1 Relevant identified uses
It is a polyurethane-based raw material suitable for producing polyurethanes with good light stability, weather resistance and excellent mechanical properties
Emergency telephone
+86 532-83889090
Icons in SDS
Company Information
company name
WANHUA CHEMICAL GROUP Co., LTD
e-mail address of the competent person responsible for the Safety Data Sheet
polyol@whchem.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H331, H334, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
H317
May cause an allergic skin reaction
H319
Causes serious eye irritation
H331
Toxic if inhaled
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335
May cause respiratory irritation
Section 2
2.1 Classification of the substance or mixture
SUMMARY OF HAZARD IN AN EMERGENCY SITUATION Liquid.Combustible. Toxic by inhalation. Irritating to eyes. Irritating to respiratory system. Irritating to skin. May cause SENSITISATION by inhalation. May cause SENSITISATION by skin contact. [1] Acute Toxicity (Inhalation) Category 3, Skin Corrosion/Irritation Category 2, Eye Irritation Category 2A, Skin Sensitizer Category 1, Respiratory Sensitizer Category 1, Specific target organ toxicity - single exposure Category 3 (respiratory tract irritation) 1. Classified by Chemwatch; 2. Classification drawn from Catalog of Hazardous Chemical; 3. Classification drawn from Regulation (EU) No 1272/2008 - Legend: Annex VI
Signal word
DANGER
Hazard statements
H331 Toxic if inhaled. H315 Causes skin irritation. H319 Causes serious eye irritation. H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation.
Prevention
P261 Avoid breathing mist/vapours/spray. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves/protective clothing/eye protection/face protection. P284 [In case of inadequate ventilation] wear respiratory protection. P272 Contaminated work clothing should not be allowed out of the workplace.
Response
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER/doctor/physician/first aider. P302+P352 IF ON SKIN: Wash with plenty of water and soap. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P337+P313 If eye irritation persists: Get medical advice/attention. P362+P364 Take off contaminated clothing and wash it before reuse.
Storage
P403+P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local regulations.
Other physicochemical hazards
Liquid.Combustible. Toxic smoke/fumes in a fire. Reacts with water.
Health hazards
Inhalation of vapours or aerosols (mists, fumes), generated by the material during the course of normal handling, may produce toxic effects. Evidence shows, or practical experience predicts, that the material produces irritation of the respiratory system, in a substantial number of individuals, following inhalation. In contrast to most organs, the lung is able to respond to a chemical insult by first removing or neutralising the irritant and then repairing the damage. The repair process, which initially evolved to protect mammalian lungs from foreign matter and antigens, may however, produce further lung damage resulting in the impairment of gas exchange, the primary function of the lungs. Respiratory tract irritation often results in an inflammatory response involving the recruitment and activation of many cell types, mainly derived from the vascular system. The vapour/mist may be highly irritating to the upper respiratory tract and lungs; the response may be severe enough to produce bronchitis and pulmonary oedema. Possible neurological symptoms arising from isocyanate exposure include headache, insomnia, euphoria, ataxia, anxiety neurosis, depression and paranoia. Gastrointestinal disturbances are characterised by nausea and vomiting. Pulmonary sensitisation may produce asthmatic reactions ranging from minor breathing difficulties to severe allergic attacks; this may occur following a single acute exposure or may develop without warning for several hours Inhaled after exposure. Sensitized people can react to very low doses, and should not be allowed to work in situations allowing exposure to this material. Continued exposure of sensitised persons may lead to possible long term respiratory impairment. Inhalation hazard is increased at higher temperatures. In rats, high doses of methylene bis(4-cyclohexylisocyanate) produced marked respiratory irritation with tremors and convulsions and severe pulmonary oedema and congestion of the lungs. Unlike TDI the material s not a sensory irritant but it depresses respiration by producing pulmonary irritation. Inhaling high vapour concentrations of this material can cause tightness of chest, shortness of breath, breathing difficulty, cough and dry throat, bronchitis with asthma-like wheezing, lung inflammation and fluid in the lung. Symptoms may not appear until several hours after exposure. Respiratory sensitisation may cause difficulty in breathing, chest tightness, a cold or mild hay fever or asthma like effect if in contact with airborne mist or vapour. Both allergy-prone and non allergy-prone people can become sensitized. Cross sensitisation to other isocyanates may occur. [Source: CHEMINFO] Sensitised individuals should not work with or near this material. Extreme care should be taken when handling this material. The material is not thought to produce adverse health effects following ingestion (as classified by EC Directives using animal models). Nevertheless, Ingestion adverse systemic effects have been produced following exposure of animals by at least one other route and good hygiene practice requires that exposure be kept to a minimum. Evidence exists, or practical experience predicts, that the material either produces inflammation of the skin in a substantial number of individuals following direct contact, and/or produces significant inflammation when applied to the healthy intact skin of animals, for up to four hours, such inflammation being present twenty-four hours or more after the end of the exposure period. Skin irritation may also be present after prolonged or repeated exposure; this may result in a form of contact dermatitis (nonallergic). The dermatitis is often characterised by skin redness (erythema) and swelling (oedema) which may progress to blistering (vesiculation), scaling and thickening of the epidermis. At the microscopic level there may be intercellular oedema of the spongy Skin Contact layer of the skin (spongiosis) and intracellular oedema of the epidermis. The material may accentuate any pre-existing dermatitis condition Open cuts, abraded or irritated skin should not be exposed to this material Entry into the blood-stream through, for example, cuts, abrasions, puncture wounds or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected. A 5% solution of methylene bis(4-cyclohexylisocyanate) caused strong erythema and oedema of the skin of guinea pigs. Rabbits treated with 0.1 mg showed severe skin reactions. Skin sensitisation can develop after working with this material for only a few days. Sensitised individuals may experience symptoms such as an itchy, red, scaly rash and swelling of arms and legs if material comes in contact with unprotected skin. Irritation of the eyes may produce a heavy secretion of tears (lachrymation). Eye Evidence exists, or practical experience predicts, that the material may cause eye irritation in a substantial number of individuals. Repeated or prolonged eye contact may cause inflammation (similar to windburn) characterised by a temporary redness of the conjunctiva (conjunctivitis); temporary impairment of vision and/or other transient eye damage/ulceration may occur. Long-term exposure to respiratory irritants may result in disease of the airways involving difficult breathing and related systemic problems. Practical evidence shows that inhalation of the material is capable of inducing a sensitisation reaction in a substantial number of individuals at a greater frequency than would be expected from the response of a normal population. Pulmonary sensitisation, resulting in hyperactive airway dysfunction and pulmonary allergy may be accompanied by fatigue, malaise and aching. Significant symptoms of exposure may persist for extended periods, even after exposure ceases. Symptoms can be activated by a variety of nonspecific environmental stimuli such as automobile exhaust, perfumes and passive smoking. Practical experience shows that skin contact with the material is capable either of inducing a sensitisation reaction in a substantial number of individuals, and/or of producing a positive response in experimental animals. Limited evidence suggests that repeated or long-term occupational exposure may produce cumulative health effects involving organs or biochemical systems. Chronic Persons with a history of asthma or other respiratory problems or are known to be sensitised, should not be engaged in any work involving the handling of isocyanates. [CCTRADE-Bayer, APMF] Isocyanate vapours/mists are irritating to the upper respiratory tract and lungs; the response may be severe enough to produce bronchitis with wheezing, gasping and severe distress, even sudden loss of consciousness, and pulmonary oedema. Possible neurological symptoms arising from isocyanate exposure include headache, insomnia, euphoria, ataxia, anxiety neurosis, depression and paranoia. Gastrointestinal disturbances are characterised by nausea and vomiting. Pulmonary sensitisation may produce asthmatic reactions ranging from minor breathing difficulties to severe allergic attacks; this may occur following a single acute exposure or may develop without warning after a period of tolerance. A respiratory response may occur following minor skin contact. Skin sensitisation is possible and may result in allergic dermatitis responses including rash, itching, hives and swelling of extremities. Isocyanate-containing vapours/ mists may cause inflammation of eyes and nasal passages. Onset of symptoms may be immediate or delayed for several hours after exposure. Sensitised people can react to very low levels of airborne isocyanates. Unprotected or sensitised persons should not be allowed to work in situations allowing exposure to this material.
Environmental hazards
See Section 12
2.3 Other hazards
Ingestion may produce serious health damage*.